Thursday, Eli Lilly and Company ( LLY ) released topline results from the SUMMIT phase 3 clinical trial evaluating the safety and efficacy of tirzepatide injection (5 mg, 10 mg, or 15 mg) in adults with heart failure with preserved ejection fraction (HFpEF) and obesity. HFpEF accounts for nearly half of all heart failure cases, and in the U.S., almost 60%...

09:45 AM EDT, 08/01/2024 (MT Newswires) -- Dun & Bradstreet ( DNB ) shares were falling past 7.7% in recent Thursday trading after the company's Q2 revenue missed analysts' estimates. The company reported Q2 adjusted earnings Thursday of $0.23 per diluted share, up from $0.22 a year earlier. Analysts polled by Capital IQ expected $0.23. Revenue for the quarter ended...

09:46 AM EDT, 08/01/2024 (MT Newswires) -- ExlService Holdings ( EXLS ) reported Q2 adjusted earnings Thursday of $0.40 per diluted share, compared with $0.36 a year earlier. Analysts polled by Capital IQ expected $0.39. Revenue for the quarter ended June 30 was $448.4 million, compared with $405 million a year earlier. Analysts expected $444.6 million. For 2024, the data...

(Reuters) -Artificial intelligence chipmaker Cerebras Systems has confidentially filed for an initial public offering in the United States as it prepares to challenge industry heavyweight Nvidia. The eight-year-old startup will court investors at a time when enthusiasm for AI remains high, boosting the fortunes of firms that supply the infrastructure critical to train chatbots. But Cerebras could face questions about...